Amgen faces EU withdrawal of Tavneos (AMGN:NASDAQ)
· seekingalpha.com
Amgen (AMGN) stock is in focus as an expert panel of the European Medicines Agency recommends withdrawal of the company's rare-disease drug, Tavneos. Read more here.
Amgen (AMGN) is facing a possible EU withdrawal of its rare-disorder therapy, Tavneos, after an expert panel of the European Medicines Agency recommended its ma...